产品详情
In vitro (25°C) | DMSO | 19 mg/mL (79.73 mM) | |
Water | Insoluble | ||
Ethanol | 2 mg/mL (8.39 mM) | ||
In vivo | 5% DMSO+40%PEG 300+ 5% Tween80 + ddH2O | 0.4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 41.97 mL | 209.84 mL | 419.67 mL |
0.5 mM | 8.39 mL | 41.97 mL | 83.93 mL |
1 mM | 4.2 mL | 20.98 mL | 41.97 mL |
5 mM | 0.84 mL | 4.2 mL | 8.39 mL |
*The above data is based on the productmolecular weight 238.28. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A12437 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 238.28 |
Formula | C15H14N2O |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 204005-46-9 |
Synonyms | SU-5416, SU5416 |
SMILES | CC1=CC(=C(N1)/C=C\2/C3=CC=CC=C3NC2=O)C |
产品标签
Product Questions
Product Questions
XL647 (Tesevatinib)
XL647 (Tesevatinib)是一种口服生物可利用的小分子RTK抑制剂,可结合并抑制在肿瘤细胞增殖和肿瘤血管形成中…
E-7050 (Golvatinib)
E-7050 (Golvatinib)是具有潜在抗肿瘤活性的c-Met(肝细胞生长因子受体)和VEGFR-2(血管内皮生长因子受体-2)酪氨酸…
Cediranib (AZD2171)
Cediranib (AZD2171)是一种高效的VEGFR(KDR)抑制剂,此外对c-Kit和PDGFRβ也具有相似的抑制活性,对VEGFR的选择性比P…
Kaempferol
Kaempferol被发现抑制Ki为0.3-0.5 μM的牛主动脉肌球蛋白轻链激酶,并且还被发现通过新的ERK-NFκB-cMyc-p21途径抑…
ZM 306416
ZM 306416 hydrochloride是一种VEGF受体酪氨酸激酶抑制剂,可抑制KDR(IC50 = 100 nM)和Flt(IC50 = 2 uM)酪氨酸激酶…
Apatinib (YN968D1)
Apatinib (YN968D1)是一种酪氨酸激酶抑制剂,可选择性抑制血管内皮生长因子受体2(VEGFR2,也称为KDR),后者…